Company Filing History:
Years Active: 2014-2016
Title: Christoph Bickel: Innovator in Cardiac Risk Stratification
Introduction
Christoph Bickel is a notable inventor based in Koblenz, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the area of cardiac health. With a total of 3 patents to his name, Bickel's work focuses on innovative methods for assessing patient risk in stable coronary artery disease.
Latest Patents
One of Christoph Bickel's latest patents is a method for risk stratification in stable coronary artery disease. This in vitro method involves determining the concentration of procalcitonin in the circulation of patients with stable arteriosclerosis. Using a highly sensitive PCT assay, the method defines cutoff values within the normal range of healthy individuals. These values help distinguish groups of patients based on their personal cardiac risk, allowing for more tailored medical care.
Career Highlights
Bickel is associated with B.R.A.H.M.S GmbH, a company that specializes in innovative diagnostic solutions. His work at the company has been instrumental in advancing the understanding and management of cardiovascular diseases. His contributions have not only enhanced patient care but have also paved the way for future research in the field.
Collaborations
Christoph Bickel has collaborated with notable colleagues such as Andreas Bergmann and Joachim Struck. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
In summary, Christoph Bickel is a distinguished inventor whose work in cardiac risk stratification has the potential to significantly impact patient outcomes. His innovative methods and collaborations continue to advance the field of medical diagnostics.